Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

David Grimwade · Blood · 2001 · 918 citations · Full text

Life Sciences, Hematology, Oncology +14

Adverse Prognostic Significance of <i>KIT</i> Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

Peter Paschka, Guido Marcucci, Amy S. Ruppert et al. · Journal of Clinical Oncology · 2006 · 666 citations

Medicine, Hematology, Oncology +17

Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies

Marcus M. Schittenhelm, Sharon Shiraga, Arin Schroeder et al. · Cancer Research · 2006 · 467 citations

Medicine, Oncology, Pharmacology +16

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger, Tobias Kohl, Torsten Haferlach et al. · Blood · 2005 · 379 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Roberto Cairoli · Blood · 2005 · 374 citations · Full text

Medicine, Hematology, Oncology +17